SAB Biotherapeutics, Inc.

Nasdaq:SABSNasdaq:SABSW

Biological Products, (No Diagnostic Substances)·MIAMI BEACH, FL

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/14/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/9/25	→
10-K	FY 2024	12/31/24	3/31/25	→
10-Q	Q3 2024	9/30/24	11/6/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

3 shown

Filed	Period
3/29/24	Q1 FY2024	→
3/31/23	Q1 FY2023	→
11/22/21	Q4 FY2021	→

News (8-K)

72 shown

Filed	Type	Description
1/12/26	Reg FD	Regulation FD Disclosure	→
1/7/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/29/25	Other	Other Events	→
9/30/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
9/26/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
7/21/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

34 shown

Filed	Form	Description
12/29/25	S-3	S-3	→
12/15/25	S-8	S-8	→
11/12/25	424B3	424B3	→
9/22/25	S-3/A	S-3/A	→
9/2/25	S-3	S-3	→
4/3/25	S-8	S-8	→
↓

Filing History(394 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Feb 17, 2026

0000921895-26-000472

—

26.5 KB

SCHEDULE 13G/A

Feb 17, 2026

0001493215-26-000048

—

10.6 KB

Feb 5, 2026

0001193125-26-0395774

Feb 3, 2026

5.5 KB

Feb 5, 2026

0001193125-26-0395644

Feb 5, 2026

5.5 KB

Feb 5, 2026

0001193125-26-0395374

Feb 3, 2026

5.5 KB

Feb 5, 2026

0001193125-26-0395244

Feb 3, 2026

5.5 KB

Feb 5, 2026

0001193125-26-0395084

Feb 3, 2026

5.5 KB

SCHEDULE 13G

Jan 22, 2026

0001193125-26-019535

—

289.9 KB

8-K

Jan 12, 2026

0001193125-26-0105158-K

Jan 12, 2026

13.5 MB

EFFECT

Jan 7, 2026

9999999995-26-000101

—

1.8 KB

Jan 7, 2026

0001193125-26-0064354

Jan 5, 2026

5.5 KB

Jan 7, 2026

0001193125-26-0064274

Jan 5, 2026

5.5 KB

Jan 7, 2026

0001193125-26-0064113

Jan 5, 2026

6.9 KB

Jan 7, 2026

0001193125-26-0064073

Jan 5, 2026

6.7 KB

8-K

Jan 7, 2026

0001193125-26-0054878-K

Jan 5, 2026

262.3 KB

S-3

Dec 29, 2025

0001193125-25-335445S-3

—

2.3 MB

8-K

Dec 29, 2025

0001193125-25-3352678-K

Dec 29, 2025

186.3 KB

Dec 18, 2025

0001193125-25-3250074

Dec 16, 2025

5.4 KB

Dec 18, 2025

0001193125-25-3250024

Dec 16, 2025

5.4 KB

Dec 18, 2025

0001193125-25-3249914

Dec 16, 2025

5.4 KB

Dec 18, 2025

0001193125-25-3249764

Dec 16, 2025

5.4 KB

Dec 18, 2025

0001193125-25-3249704

Dec 16, 2025

5.4 KB

Dec 18, 2025

0001193125-25-3249634

Dec 16, 2025

5.4 KB

S-8

Dec 15, 2025

0001193125-25-319278S-8

—

408.6 KB

Dec 12, 2025

0001193125-25-3176884

Dec 11, 2025

5.1 KB

25 filings shown

Filed	Form	Description
8/29/25	DEF 14A	DEF 14A	→
8/19/25	PRE 14A	PRE 14A	→
6/2/25	DEF 14A	DEF 14A	→
5/30/24	DEF 14A	DEF 14A	→
12/18/23	DEF 14A	DEF 14A	→
12/8/23	PRE 14A	PRE 14A	→
↓

SAB Biotherapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(394 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/5/26	4	4	→
2/5/26	4	4	→
2/5/26	4	4	→
2/5/26	4	4	→
2/5/26	4	4	→
1/7/26	4	4	→
↓

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
1/22/26	SCHEDULE 13G	SCHEDULE 13G	→
1/7/26	EFFECT	EFFECT	→
11/14/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
11/14/25	SCHEDULE 13G	SCHEDULE 13G	→
↓